NPI: 1891801734 · ELIZABETHTON, TN 37643 · General Acute Care Hospital · NPI assigned 08/22/2006
Authorized official HILTON, SHANE controls 20+ related entities in our dataset. Read more
| Authorized Official | HILTON, SHANE (EVP/CFO) |
| NPI Enumeration Date | 08/22/2006 |
Other providers sharing the same authorized official: HILTON, SHANE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 40,768 | $1.57M |
| 2019 | 32,949 | $1.23M |
| 2020 | 20,439 | $982K |
| 2021 | 17,570 | $966K |
| 2022 | 15,908 | $1.01M |
| 2023 | 16,489 | $864K |
| 2024 | 10,265 | $632K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 16,656 | 15,042 | $2.94M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,775 | 8,652 | $1.97M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,831 | 11,145 | $1.43M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,292 | 2,021 | $195K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,908 | 7,057 | $178K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 18,106 | 15,346 | $60K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 608 | 574 | $55K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 838 | 794 | $54K |
| 84484 | 6,264 | 4,186 | $46K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 726 | 652 | $42K |
| G0378 | Hospital observation service, per hour | 732 | 624 | $38K |
| 80053 | Comprehensive metabolic panel | 15,231 | 13,107 | $37K |
| 70450 | Computed tomography, head or brain; without contrast material | 869 | 764 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,874 | 5,097 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,675 | 2,312 | $15K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 54 | 44 | $14K |
| 83690 | 3,463 | 3,104 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,067 | 1,963 | $13K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 265 | 247 | $10K |
| 36415 | Collection of venous blood by venipuncture | 10,264 | 7,731 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 487 | 430 | $9K |
| 84703 | 1,471 | 1,374 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,340 | 2,058 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 1,672 | 1,558 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,410 | 1,374 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,094 | 1,000 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,048 | 862 | $5K |
| 71045 | Radiologic examination, chest; single view | 2,642 | 2,340 | $5K |
| 87077 | 1,661 | 1,614 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,534 | 1,894 | $3K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 318 | 173 | $3K |
| 81001 | 4,648 | 4,207 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 238 | 221 | $2K |
| 85027 | 1,090 | 891 | $2K | |
| 80061 | Lipid panel | 232 | 225 | $2K |
| 85730 | 863 | 743 | $2K | |
| 85610 | 1,371 | 1,159 | $2K | |
| 87088 | 377 | 347 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 73 | 63 | $2K |
| 74022 | 213 | 201 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 27 | 26 | $1K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 18 | 18 | $1K |
| 81003 | 2,302 | 2,067 | $1K | |
| 83735 | 576 | 437 | $1K | |
| 87040 | 384 | 196 | $892.76 | |
| 84443 | Thyroid stimulating hormone (TSH) | 191 | 174 | $841.49 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,962 | 1,735 | $799.65 |
| 83880 | 146 | 125 | $779.75 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 18 | 17 | $718.34 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 30 | 28 | $707.77 |
| 96376 | 116 | 55 | $642.00 | |
| 87081 | 126 | 112 | $625.06 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 33 | 29 | $613.72 |
| 81025 | 178 | 168 | $474.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 181 | 91 | $325.78 |
| 73630 | 31 | 31 | $272.53 | |
| 87186 | 54 | 52 | $271.52 | |
| 73610 | 33 | 28 | $260.56 | |
| 72100 | 68 | 65 | $248.69 | |
| 12001 | 14 | 12 | $219.18 | |
| 73130 | 31 | 28 | $176.41 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 135 | 119 | $156.65 |
| 82607 | 70 | 52 | $125.70 | |
| 73562 | 14 | 13 | $114.10 | |
| 84134 | 47 | 40 | $106.61 | |
| 73030 | 13 | 12 | $97.80 | |
| 84100 | 90 | 68 | $79.42 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 971 | 897 | $75.91 |
| 83036 | Hemoglobin; glycosylated (A1C) | 44 | 43 | $68.11 |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16 | 15 | $64.91 |
| 87807 | 13 | 13 | $52.04 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 188 | 166 | $46.37 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 12 | 12 | $30.71 |
| J7030 | Infusion, normal saline solution , 1000 cc | 439 | 397 | $22.68 |
| 86803 | 12 | 12 | $18.20 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 15 | 13 | $9.18 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 17 | 13 | $7.50 |
| J2704 | Injection, propofol, 10 mg | 274 | 215 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 44 | 37 | $0.00 |
| 80320 | 15 | 13 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 27 | 24 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 36 | 36 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 97 | 79 | $0.00 |